Hyperion DeFi (NASDAQ:HYPD) Rating Increased to Hold at Zacks Research

Hyperion DeFi (NASDAQ:HYPD) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

HYPD has been the topic of a number of other research reports. Cantor Fitzgerald increased their price target on shares of Hyperion DeFi from $4.00 to $6.60 and gave the stock an “overweight” rating in a research note on Wednesday, July 1st. Chardan Capital cut their target price on Hyperion DeFi from $8.25 to $7.30 and set a “buy” rating on the stock in a research report on Monday, June 8th. Finally, Weiss Ratings upgraded Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, June 24th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $6.95.

Hyperion DeFi Price Performance

HYPD opened at $3.02 on Tuesday. The company’s 50 day simple moving average is $3.30 and its 200 day simple moving average is $3.47. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.97 and a current ratio of 1.97. Hyperion DeFi has a 1 year low of $2.49 and a 1 year high of $16.12. The stock has a market capitalization of $45.78 million, a PE ratio of -0.30 and a beta of 2.49.

Insider Transactions at Hyperion DeFi

In related news, insider Hyunsu Jung acquired 7,000 shares of Hyperion DeFi stock in a transaction on Monday, June 1st. The shares were bought at an average price of $3.70 per share, for a total transaction of $25,900.00. Following the completion of the purchase, the insider directly owned 1,384,676 shares in the company, valued at $5,123,301.20. This trade represents a 0.51% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 7.50% of the company’s stock.

Institutional Investors Weigh In On Hyperion DeFi

Several hedge funds have recently modified their holdings of HYPD. Renaissance Technologies LLC purchased a new position in Hyperion DeFi in the 4th quarter worth approximately $663,000. Jane Street Group LLC purchased a new stake in shares of Hyperion DeFi during the fourth quarter valued at approximately $493,000. Focus Partners Advisor Solutions LLC purchased a new stake in shares of Hyperion DeFi during the fourth quarter valued at approximately $221,000. Geode Capital Management LLC acquired a new position in shares of Hyperion DeFi during the fourth quarter worth $214,000. Finally, Investment House LLC acquired a new position in shares of Hyperion DeFi during the fourth quarter worth $166,000. 25.84% of the stock is currently owned by hedge funds and other institutional investors.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.